Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aromatase inhibitors for breast cancer.
Briest S, Davidson NE. Briest S, et al. Rev Endocr Metab Disord. 2007 Sep;8(3):215-28. doi: 10.1007/s11154-007-9039-z. Rev Endocr Metab Disord. 2007. PMID: 17486453 Review.
Metastasizing signet ring cell carcinoma of the stomach-mimicking bilateral inflammatory breast cancer.
Briest S, Horn LC, Haupt R, Schneider JP, Schneider U, Höckel M. Briest S, et al. Gynecol Oncol. 1999 Sep;74(3):491-4. doi: 10.1006/gyno.1999.5478. Gynecol Oncol. 1999. PMID: 10479517 Review.
Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer.
Briest S, Wolff AC. Briest S, et al. Expert Rev Anticancer Ther. 2007 Sep;7(9):1243-53. doi: 10.1586/14737140.7.9.1243. Expert Rev Anticancer Ther. 2007. PMID: 17892424 Review.
Chemotherapeutic Strategies for advanced breast cancer.
Briest S, Stearns V. Briest S, et al. Oncology (Williston Park). 2007 Oct;21(11):1325-35; discussion 1338, 1340. Oncology (Williston Park). 2007. PMID: 18080617 Review.
Adjuvant aromatase inhibitors and emerging quality-of-life considerations.
Briest S, Stearns V. Briest S, et al. Expert Rev Anticancer Ther. 2008 Jan;8(1):1-4. doi: 10.1586/14737140.8.1.1. Expert Rev Anticancer Ther. 2008. PMID: 18095876 No abstract available.
Tamoxifen metabolism and its effect on endocrine treatment of breast cancer.
Briest S, Stearns V. Briest S, et al. Clin Adv Hematol Oncol. 2009 Mar;7(3):185-92. Clin Adv Hematol Oncol. 2009. PMID: 19398943 Review.
It has been increasingly recognized in recent years that pharmacogenetics may play a role in tamoxifen's metabolism, efficacy, and safety. ...Variant alleles in CYP2D6 or the use of medications that inhibit the enzyme clearly influence tamoxifen's metabolism into en …
It has been increasingly recognized in recent years that pharmacogenetics may play a role in tamoxifen's metabolism, efficacy, and sa …
Advances in the adjuvant and neoadjuvant treatment of breast cancer.
Briest S, Stearns V. Briest S, et al. Womens Health (Lond). 2007 May;3(3):325-39. doi: 10.2217/17455057.3.3.325. Womens Health (Lond). 2007. PMID: 19803992
Invasive Lobular Carcinoma of the Male Breast: A Rare Histology in an Uncommon Disease.
Briest S, Vang R, Terrell K, Emens L, R Lange J. Briest S, et al. Breast Care (Basel). 2009;4(1):36-38. doi: 10.1159/000190078. Epub 2009 Feb 20. Breast Care (Basel). 2009. PMID: 20877682 Free PMC article.
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer.
Stearns V, Jacobs LK, Fackler M, Tsangaris TN, Rudek MA, Higgins M, Lange J, Cheng Z, Slater SA, Jeter SC, Powers P, Briest S, Chao C, Yoshizawa C, Sugar E, Espinoza-Delgado I, Sukumar S, Gabrielson E, Davidson NE. Stearns V, et al. Among authors: briest s. Clin Cancer Res. 2013 Jul 15;19(14):4008-16. doi: 10.1158/1078-0432.CCR-13-0033. Epub 2013 May 29. Clin Cancer Res. 2013. PMID: 23719261 Free PMC article. Clinical Trial.
Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer.
Kast K, Schmutzler RK, Rhiem K, Kiechle M, Fischer C, Niederacher D, Arnold N, Grimm T, Speiser D, Schlegelberger B, Varga D, Horvath J, Beer M, Briest S, Meindl A, Engel C. Kast K, et al. Among authors: briest s. Int J Cancer. 2014 Nov 15;135(10):2352-61. doi: 10.1002/ijc.28875. Epub 2014 Apr 25. Int J Cancer. 2014. PMID: 24700448
44 results
Jump to page
Feedback